HNRIX | VENAX | HNRIX / VENAX | |
Total Expense Ratio | 2.11 | 0.09 | 2,344% |
Annual Report Gross Expense Ratio | 2.28 | 0.09 | 2,533% |
Fund Existence | 12 years | 21 years | - |
Gain YTD | 4.907 | 1.615 | 304% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 100000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.4M | 9B | 0% |
Annual Yield % from dividends | 0.13 | 3.07 | 4% |
Returns for 1 year | 13.07 | 2.77 | 471% |
Returns for 3 years | 29.37 | 8.35 | 352% |
Returns for 5 years | 253.95 | 173.21 | 147% |
Returns for 10 years | 108.85 | 38.97 | 279% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UAUG | 38.83 | 0.03 | +0.08% |
Innovator U.S. Equity Ultra BufferETFAug | |||
CPRA | 26.01 | 0.01 | +0.02% |
Calamos Russell 2000 Str Alt Prt ETF-Apr | |||
DYYXF | 2.69 | N/A | N/A |
Deutsche Bank AG (London Branch) | |||
VPC | 20.66 | -0.07 | -0.34% |
Virtus Private Credit ETF | |||
BMEZ | 14.56 | -0.06 | -0.41% |
BlackRock Health Sciences Term Trust |